About us
DEVELOPMENT AND COMMERCIALIZATION OF PRODUCTS ORIENTED TO THE CLINICAL AND HOSPITAL SECTOR
Nexotech was born in 2022, as a result of the business association of two Galician biotech companies: AMSlab and Nasasbiotech.
Its main activity is based on the research, development, manufacture and marketing of products and services in the area of human and veterinary health, as well as kits for analysis and research aimed at the clinical and hospital sector.
The AMSlab Group, through companies such as CIFGA, is currently working on the development of kits for analysis and research and has extensive experience in the commercialization of products worldwide. In this way, it is complemented by the other party, Nasasbiotech, which provides know-how and technologies for the development of new products and new solutions for the health sector.
The synergies between the two Galician companies create the perfect tandem. On the one hand, the knowledge in the clinical and oncological sector and the development of solutions focused on facilitating the daily tasks of professionals, and on the other hand, the experience in the manufacture and marketing of this type of products.
Our origins
Leading group of biotechnology companies established in 2008 whose mission is focused on providing analytical solutions and/or products in those sectors in which their companies currently have scope; food, veterinary, pharmaceutical and clinical industry.
Laboratory located in Lugo, experts in quality control in different sectors. Its mission is to help its clients to comply with the established standards, guaranteeing the quality and safety of their products on the market.
Nasasbiotech: spin-off of the Instituto de Investigación Sanitaria de Santiago de Compostela FIDIS, based in A Coruña and specialised in the development of novel clinical solutions to improve the diagnosis, prognosis and treatment of cancer.
Why we exist
The synergies between the two Galician companies create the perfect tandem. On the one hand, the knowledge in the clinical and oncological sector and the development of solutions focused on facilitating the daily tasks of professionals, and on the other hand, the experience in the manufacture and marketing of this type of products.
Mission
To simplify and standardize access to high-performance, cost-efficient exosome purification. Empowering discovery, innovation, and translational impact across sectors
Vision
To set the global standard in exosome purification. Advancing and enabling innovation in diagnostics and therapeutics across human and animal health.
Values
Innovation, high technology, experience, solutions, high reliability quiality.